Catalyst Wire Dossier Catalyst Wire Dossier

Budesonide/Glycopyrronium/Formoterol

budesonide/glycopyrronium/formoterol · AstraZeneca
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Budesonide/Glycopyrronium/Formoterol, covering 2026-02-02 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

See pricing